LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Lixte Biotechnology Holdings, Inc. Return On Equity for the quarter ending June 30, 2024 was -113 %, a 15.7% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Return On Equity for 2023 was -130 %, a 15.8% decline from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Return On Equity for 2022 was -112 %, a 5.63% decline from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Return On Equity for 2021 was -106 %, a 19.8% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -113 +21.1 +15.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -127 -23.2 -22.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -130 -17.7 -15.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -135 -13.8 -11.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -134 -15.4 -13% Apr 1, 2023 Jun 30, 2023
Q1 2023 -104 +21.5 +17.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -112 -5.97 -5.63% Oct 1, 2022 Dec 31, 2022
Q3 2022 -121 -33.5 -38.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -119 -3.05 -2.64% Apr 1, 2022 Jun 30, 2022
Q1 2022 -126 -6.49 -5.45% Jan 1, 2022 Mar 31, 2022
Q4 2021 -106 +26.1 +19.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -87.6 +59.2 +40.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -116 -18.8 -19.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -119 -29.1 -32.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -132 -52.8 -66.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -147 -76.2 -108% Jul 1, 2020 Sep 30, 2020
Q2 2020 -96.8 -10.4 -12% Apr 1, 2020 Jun 30, 2020
Q1 2020 -90.1 +18.2 +16.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -79.4 +92.2 +53.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -70.5 +411 +85.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -86.4 +116 +57.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -108 +21.6 +16.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -172 -23.4 -15.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -482 -297 -161% Jul 1, 2018 Sep 30, 2018
Q2 2018 -203 +38.8 +16.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -130 +198 +60.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -148 +117 +44% Oct 1, 2017 Dec 31, 2017
Q3 2017 -185 +84.2 +31.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -241 +37.9 +13.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -327 -61.4 -23.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -265 +29.8 +10.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -269 +27.4 +9.25% Jul 1, 2016 Sep 30, 2016
Q2 2016 -279 +3.53 +1.25% Apr 1, 2016 Jun 30, 2016
Q1 2016 -266 +76.8 +22.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -295 +342 +53.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 -296 +296 +50% Jul 1, 2015 Sep 30, 2015
Q2 2015 -283 +270 +48.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -343 +150 +30.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -636 -447 -236% Oct 1, 2014 Dec 31, 2014
Q3 2014 -592 -468 -377% Jul 1, 2014 Sep 30, 2014
Q2 2014 -553 -329 -148% Apr 1, 2014 Jun 30, 2014
Q1 2014 -493 -283 -134% Jan 1, 2014 Mar 31, 2014
Q4 2013 -189 +106 +36% Oct 1, 2013 Dec 31, 2013
Q3 2013 -124 +339 +73.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -223 +235 +51.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -210 +391 +65.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -296 Oct 1, 2012 Dec 31, 2012
Q3 2012 -463 Jul 1, 2012 Sep 30, 2012
Q2 2012 -458 Apr 1, 2012 Jun 30, 2012
Q1 2012 -601 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.